Simple syntheses of two new benzo-fused macrocycles incorporating chalcone moiety.
Chalcones (1,3-diphenyl-2-propen-1-ones)  are known to possess a range of important biological activities, such as antibacterial , antifungal , antileishmanial , antimalarial , antifilarial  anti-inflammatory [6-8], antiprotozoal (antileishmanial and antipanosomal) , antimicrobial [10-13], larvicidal , anticonvulsant , anti-HIV , antitumor , and anticancer  activities, and they could be readily transformed into varieties of other compounds, many of which are biologically active heterocycles [19, 20]. Owing to such biological activities of chalcones, the chemical literature shows the synthesis of a wide range of chalcones and their analogues [4, 8-13, 21-23]. Again, since macrocyclic compounds are well-known for their ability to show the important property of molecular recognition, macrocyclic systems containing the chalcone moiety are expected to generate compounds having interesting biological and material properties [24, 25]. Our research on such compounds has been initiated through the synthesis of a number of macrocyclic bis- and monochalcones reported recently . In continuation of that study we have synthesized a benzo-fused 26-membered macrocyclic bischalcone, namely, (19E,43E)-184.108.40.206-tetroxaheptacyclo [44.4.0.[0.sup.4,9].[0.sup.12,17].[0.sup.21,26].[0.sup.29,34].[0.sup.37,42]] pentaconta-1(46),4(9),5, 7,12(17),13,15,19,21,23,25,29,31,33,37,39,41,43,47,49-icosaene 18,45-dione (3), and a benzo-fused 13-membered macrocyclic monochalcone, namely, (19E)-2.11-dioxatetracyclo[19.4.0. [0.sup.4,9].[0.sup.12,17]] pentacosa-1(25),4(9),5,7,12(17),13,15,19,21,23-decaen-18-one (5), by use of readily available starting materials. Herein we report the synthesis of these two hitherto unknown compounds.
2. Results and Discussion
Alkylation products of salicylaldehyde and o-hydroxyacetophenone by the use of 1,2-(bis-bromobenzyl)benzene as alkylating agent were first prepared. The resulting dialdehyde (1) and diketone (2), both new compounds, were then subjected to Claisen-Schmidt reaction under high dilution condition when the macrocyclic bischalcone 3 was obtained in moderate yield (Scheme 1). In order to achieve the synthesis of 5, 2,2,-dihydroxychalcone (4) was first constructed from o-hydroxyacetophenone and salicylaldehyde by Claisen-Schmidt reaction. The reaction between 4 and 1,2(bis-bromobenzyl)benzene was then done by following the typical procedure for alkylation of phenols ([K.sub.2]C[O.sub.3]/acetone, reflux, 12 h) (Scheme 2). This reaction gave 5 in very good yield and no trace of any macrocyclic bischalcone 7 (a possible product through bimolecular cyclization of the intermediate 6) Scheme 3).
[FORMULA NOT REPRODUCIBLE IN ASCII]
[FORMULA NOT REPRODUCIBLE IN ASCII]
The new compounds 3 and 5 were characterized from their analytical and spectral data which are presented in the Experimental Section as well as in the Supplementary File in the Supplementary Material available online at http://dx.doi.org/10.1155/2014/485014.
Melting points were taken in open capillary tubes and are uncorrected. IR spectra were recorded on a Perkin Elmer FT-IR spectrophotometer (Spectrum BX II) in KBr pellets. [sup.1]H and [sup.13]C NMR spectra were recorded in CD[Cl.sub.3] on a Bruker AV-300 (300 MHz) spectrometer. Analytical samples were routinely dried in vacuo at room temperature. Microanalytical data were recorded on a Perkin-Elmer 2400 Series II C, H, N analyzer. ESIMS(+) mass spectrum of 3 was measured with a Waters Micromass Q-Tof micro instrument. Column chromatography was performed with silica gel (100-200 mesh) and TLC with silica gel G made of SRL Pvt. Ltd. Petroleum ether used had the boiling range of 60-80[degrees]C.1 H and [sup.13]C NMR and mass spectra of different compounds can be found in the Supplementary Material.
3.1. 1,2-Bis(bromomethyl)benzene. This compound was prepared from o-xylene by benzylic bromination with NBS [NBS (2.2 equiv.), [(PhCOO).sub.2] (trace), refluxed in C[Cl.sub.4], 12 h, yield: 83%), m.p. 94[degrees]C (lit.  92-96[degrees]C); [sup.1]H NMR (CD[Cl.sub.3]): [delta] 4.66 (br. s, 4H, -C[[H.bar].sub.2]-Br), 7.29-7.31 (m, 2H, Ar-H), 7.33-7.38 (m, 2H, Ar-H).
3.2.1,2-Bis(2-formylphenoxymethyl)benzene (1). A mixture of salicylaldehyde (2 mmol) and 1,2-bis(bromomethyl)benzene (1 mmol) was refluxed in methanolic KOH (5%, 25 mL) for 7h. Removal of methanol by distillation and addition of water followed by extraction with ethyl acetate gave crude alkylation product 1, which was purified by rapid column chromatography followed by crystallization from CH[Cl.sub.3] petroleum ether (yield: 66%). The physical and spectral data of 1 were as follows: colourless needles, m.p. 118-120[degrees]C; 1H NMR (300 MHz, CD[Cl.sub.3]): [delta] 5.31 (br. s, 4H, 2 x -OC[H.sub.2-]), 7.05 (dt, 4H, J = 7.2 and 1.5 Hz), 7.42-7.45 (m, 2H, ArH), 7.50-7.57 (m, 4H), 782 (dd, 2H, J = 7.8 and 1.8 Hz), and 10.45 (br. s, 2H, 2 x -C[H.bar]O).
3.3. 1,2-Bis(2-acetylphenoxymethyl)benzene (2). A mixture of o-hydroxyacetophenone (2 mmol), 1,2-bis(bromomethyl) benzene (1mmol) and anhydrous [K.sub.2]C[O.sub.3] (3g.) was refluxed in dry acetone for 12 h. Usual work-up followed by purification of the resulting crude material by column chromatography over silica gel afforded pure 2 (yield: 78%). The physical and spectral data of 2 were as follows: colourless needles (CH[Cl.sub.3]-petroleum ether), m.p. 74[degrees]C; [sup.1]H NMR (300 MHz, CD[Cl.sub.3]): 5 2.53 (s, 6H, 2 x -COC[H.sub.3]), 5.27 (br. s, 4H, -OC[H.sub.2]), 7.03 (dt, 4H, J = 8.4 and 1.8 Hz), 7.40-7.46 (m, 4H), 7.54 (dt, 2H, J = 8.4 and 1.8 Hz), and 7.71 (dd, 2H, J = 7.8 and 1.8 Hz).
3.4. (19E,43E)-2.n.27.36-Tetroxaheptacyclo[44.4.0.[0.sup.4,9].[0.sup.12,17]. [0.sup.21,26].[0.sup.29,34].[0.sup.37,42]]pentaconta-1(46), 4(9), 5,7,.12(17), 13,15,19,21, 23,25,29,31,33,37, 39,41,43,47,49-icosaene-18,45-dione (3). A mixture of the dialdehyde 1 (1 mmol) and the diketone 2 (1mmol) was dissolved in a KOH solution (10%, 75 mL) in MeOH-[H.sub.2]O (3 : 1) and the mixture was stirred at room temperature. A precipitate began to be formed after ca. 5 h of stirring. The stirring was continued for 72 h and then the solid was collected. The solid thus obtained was almost pure and it was further purified by column chromatography over silica gel followed by crystallization from CH[Cl.sub.3]-petroleum ether (yield: 49%). The analytical and spectral data of the macrocyclic product 3 were as follows: light yellow cubes; m.p. 205-207[degrees]C; IR (KBr, [cm.sup.-1]): 1598 (C=O), 1567, 1485, 1446,1384 [cm.sup.-1]; [sup.1]H NMR (300 MHz, CD[Cl.sub.3]): [delta] 4.85 (s, 4H, -O-C[[H.bar].sub.2-]), 5.06 (s, 4H, -C[[H.bar].sub.2-]O-), 6.77 (d, 4H, J = 72 Hz), 6.80 (t, 2H, J = 7.5 Hz), 6.97 (t, 4H, J = 7.8 Hz), 7.18-7.26 (m, 10H), 7.27 (d, 2H, J = 16.2 Hz, 2 x H-[alpha]), 7.38 (dt, 2H, J = 7.5 and 1.5 Hz), 7.47 (dd, 2H, J = 8.4 and 1.5 Hz), 7.70 (d, 2H, J = 16.2 Hz, 2 x H-[beta]); [sup.13]C NMR (75 MHz, CD[Cl.sub.3]): S 68.23, 68.48, 112.47, 112.75, 121.04, 121.21, 123.98, 127.65, 128.10, 128.11, 128.48, 129.40, 129.60, 130.10, 130.21, 131.47, 132.23, 133.81,134.42,140.17, 156.42,157.10,194.64 (C=O); MS (TOF MS [ES.sup.+]): m/z 707.18 [(M+Na).sup.+], 685.19 [(M+H).sup.+]. Elemental analysis: Calcd. for [C.sub.46][H.sub.36][O.sub.6]:C, 80.68; H, 5.30. Found: C, 80.56; H 5.42%.
[FORMULA NOT REPRODUCIBLE IN ASCII]
3.5. 2,2 -Dihydroxychalcone (4). This chalcone was prepared by condensation of o-hydroxyacetophenone and salicylaldehyde with aqueous alkali, m.p. 162-164[degrees]C (lit.  168[degrees]C). [sup.1]H NMR (300 MHz, CD[Cl.sub.3]): [delta] 5.74 (br. s, 1H, 2-OH), 6.88 (br. d, 1H, J = 8.1 Hz), 6.94-7.07 (m, 3H), 7.32 (dt, 1H, J = 78 and 1.8 Hz), 752 (dt, 1H, J = 7.5 and 1.5 Hz), 7.63 (dd, 1H, J = 78 and 1.9 Hz), 7.87 (d, 1H, J = 15.6 Hz, H-[alpha]), 7.96 (dd, 1H, J = 8.1 and 1.5 Hz), 8.21 (d, 1H, J = 15.6 Hz, H-[beta]), 12.92 (s, 1H, 2'-OH). 3.6. (19E)-2.U-Dioxatetracyclo[19.4.0.()4'9.012'17]pentacosa-1(25),4(9),5,7,12(17),13,15,19,21,23-decaen-18-one (5). To a mixture of 4 (1mmol) and 1,2-bis(bromomethyl)benzene (1mmol) in dry acetone (25 mL), anhydrous [K.sub.2]C[O.sub.3] (3g) was added and the mixture was refluxed with stirring for 12 h. Usual work-up of the reaction mixture followed by chromatography of the crude product over silica gel using petroleum ether-ethyl acetate (90: 10, v/v) gave pure 5 as light yellow crystals (yield: 57%), m.p. 160-162[degrees]C, IR (KBr) [cm.sup.-1]: 3028,2903,1585,1562,1470,1453,1436,1297,1249,1152, 1058, 960, 745. [sup.1]H NMR (300 MHz, CD[Cl.sub.3]): S 5.28 (s, 4H, 2 x ArC[H.sub.2][O.sub.-]), 7.01-7.10 (m, 2H), 7.11 (d, 1H, J = 16.5 Hz, H-[alpha]), 7.23-7.38 (m, 7H), 7.45-7.51 (m, 2H), 7.58 (dd, 1H, J = 75 and 1.8 Hz, proton ortho to C=O), 7.66 (d, 1H, J = 16.5 Hz, H-[beta]), [sup.13]C NMR (75 MHz, CD[Cl.sub.3]): S 68.65, 71.70, 113.51, 119.01, 121.67, 123.46, 128.43, 128.81, 129.19, 129.77, 129.79, 129.87, 130.68, 130.88, 131.89, 132.62, 135.18, 135.29, 141.56, 156.71, 156.97, 195.23. MS (TOF MS [ES.sup.+]): m/z [(M+Na).sup.+] 365.00. Elemental analysis: Calcd. for [C.sub.23][H.sub.18][O.sub.3]: C, 80.68; H, 5.30. Found: C, 80.45; H, 5.44%.
Thus, we report very simple syntheses of two new benzofused macrocycles incorporating chalcone moiety by the use of very common starting materials. The compounds may find important applications.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Financial assistance from the DST-PURSE program, Department of Chemistry, and the UGC-UPE-II program to Jadavpur University is gratefully acknowledged. The authors also acknowledge the DST-FIST program to the Department of Chemistry, Jadavpur University, for providing the NMR spectral data. Rina Mondal and Saheli Sarkar are thankful to the UGC and Swati Samanta is thankful to the CSIR, New Delhi, for their research fellowships.
 D. N. Dhar, The Chemistry of Chalcones and Related Compounds, John Wiley & Sons, New York, NY, USA, 1981.
 A. Solankee, S. Lad, S. Solankee, and G. Patel, "Chalcones, pyrazolines and aminopyrimidines as antibacterial agents," Indian Journal of Chemistry B, vol. 48, no. 10, pp. 1442-1446, 2009.
 L. Svetaz, A. Tapia, S. N. Lopez et al., "Antifungal chalcones and new caffeic acids esters from Zuccagnia punctata acting against soybean infecting fungi," Journal of Agricultural and Food Chemistry, vol. 52, no. 11, pp. 3297-3300, 2004.
 C. E. Gutteridge, J. V Vo, C. B. Tillett et al., "Antileishmanial and antimalarial chalcones: synthesis, efficacy and cytotoxicity
of pyridinyl and naphthalenyl analogs," Medicinal Chemistry, vol. 3, no. 2, pp. 115-119, 2007
 S. K. Awasthi, N. Mishra, S. K. Dixit et al., "Short report: anti-filarial activity of 1,3-diarylpropen-1-one: effect on glutathiones-transferase, a phase ii detoxification enzyme," The American Journal of Tropical Medicine and Hygiene, vol. 80, no. 5, pp. 764768, 2009.
 M. J. Alcaraz, A. M. Vicente, A. Araico, J. N. Dominguez, M. C. Terencio, and M. L. Ferrandiz, "Role of nuclear factor-xB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells," British Journal of Pharmacology, vol. 142, no. 7, pp. 1191-1199, 2004.
 Z. Nowakowska, "A review of anti-infective and anti-inflammatory chalcones," European Journal of Medicinal Chemistry, vol. 42, no. 2, pp. 125-137, 2007
 J.-H. Jeon, S.-J. Kim, C. G. Kim, J.-K. Kim, and J.-G. Jun, "Synthesis of biologically active chalcones and their anti-inflammatory effects," Bulletin of the Korean Chemical Society, vol. 33, no. 3, pp. 953-957, 2012.
 F. Hayat, E. Moseley, A. Salahuddin, R. L. van Zyl, and A. Azam, "Antiprotozoal activity of chloroquinoline based chalcones," European Journal of Medicinal Chemistry, vol. 46, no. 5, pp. 1897-1905, 2011.
 B. Baviskar, S. Patel, S. S. Khadebadi, and M. Shiradkar, "Design and synthesis of some novel chalcones as potent antimicrobial agent," Asian Journal of Research in Chemistry, vol. 1, no. 2, pp. 67-69, 2008.
 A. Solankee, K. Kapadia, M. Sokovic, I. Doytchinova, and A. Geronikaki, "Synthesis of some new S-triazine based chalcones and their derivatives as potent antimicrobial agents," European Journal of Medicinal Chemistry, vol. 45, no. 2, pp. 510-518,2010.
 B. Tiwari, A. S. Pratapwar, A. R. Tapas, S. R. Butle, and B. S. Vatkar, "Synthesis and antimicrobial activity of some chalcone derivatives," International Journal of ChemTech Research, vol. 2, no. 1, pp. 499-503, 2010.
 Y. R. Prasad, A. L. Rao, and R. Rambabu, "Synthesis and antimicrobial activity of some chalcone derivatives," E-Journal of Chemistry, vol. 5, no. 3, pp. 461-466, 2008.
 N. A. Begum, N. Roy, R. A. Laskar, and K. Roy, "Mosquito larvicidal studies of some chalcone analogues and their derived products: structure-activity relationship analysis," Medicinal Chemistry Research, vol. 20, no. 2, pp. 184-191, 2011.
 S. Genovese, F. Epifano, M. Curini, M. Dudra-Jastrzebska, and J. J. Luszczki, "Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents," Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 18, pp. 5419-5422, 2009.
 J.-H. Wu, X.-H. Wang, Y.-H. Yi, and K.-H. Lee, "Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos," Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 10, pp. 1813-1815, 2003.
 S. Shibata, "Anti-tumorigenic chalcones," Stem Cells, vol. 12, no. 1, pp. 44-52,1994.
 V. R. Solomon and H. Lee, "Anti-breast cancer activity of heteroaryl chalcone derivatives," Biomedicine & Pharmacotherapy, vol. 66, no. 3, pp. 213-220, 2012.
 A. Voskiene and V. Mickevicius, "Cyclization of chalcones to isoxazole and pyrazole derivatives," Chemistry of Heterocyclic Compounds, vol. 45, no. 12, pp. 1485-1488, 2009.
 G. Sandeep, Y. S. Ranganath, S. Bhasker, and N. Rajkumar, "Synthesis and biological screening of some novel Coumarin derivatives," Asian Journal of Research in Chemistry, vol. 2, no. 1, pp. 46-48, 2009.
 K. A. Brien, R. K. Bandi, A. K. Behera et al., "Design, synthesis and cytotoxicity of novel chalcone analogs derived from 1-cyclohexylpyrrolidin-2-one and 2,3-dihydrobenzo[f]chromen1-one," Archiv der Pharmazie--Chemistry in Life Sciences, vol. 345, no. 5, pp. 341-348, 2012.
 V. Satam, R. K. Bandi, A. K. Behera et al., "Design, synthesis, and cytotoxicity of novel 3-arylidenones derived from alicyclic ketones," Chemical Biology and Drug Design, vol. 78, no. 4, pp. 700-708, 2011.
 V. Satam, R. K. Bandi, A. K. Behera et al., "Design, synthesis and cytotoxicity of chalcone analogs derived from 2-phenylimino-3-phenylthiazolidin-4-one," Letters in Drug Design and Discovery, vol. 8, no. 8, pp. 704-708, 2011.
 R. Matsushima, S. Fujimoto, and K. Tokumura, "Dual photochromic properties of 4-dialkylamino-2-hydroxychalcones," Bulletin of the Chemical Society of Japan, vol. 74, no. 5, pp. 827832, 2001.
 K. Rurack, M. L. Dekhtyar, J. L. Bricks, U. Resch-Genger, and W. Rettig, "Quantum yield switching of fluorescence by selectively bridging single and double bonds in chalcones: involvement of two different types of conical intersections," Journal of Physical Chemistry A, vol. 103, no. 48, pp. 9626-9635,1999.
 R. Mondal, T. K. Mandal, and A. K. Mallik, "Simple synthesis of a new family of 22- to 28-membered macrocycles containing two chalcone moieties," Arkivoc, vol. 2012, no. 9, pp. 95-110, 2012.
 A. R. Alcantara, J. M. Marinas, and J. V. Sinisterra, "Synthesis of 2,-hydroxychalcones and related compounds in interfacial solid-liquid conditions," Tetrahedron Letters, vol. 28, no. 14, pp. 1515-1518, 1987.
Rina Mondal, Swati Samanta, Saheli Sarkar, and Asok K. Mallik
Department of Chemistry, Jadavpur University, Kolkata 700 032, India
Correspondence should be addressed to Asok K. Mallik; firstname.lastname@example.org
Received 28 June 2014; Revised 27 September 2014; Accepted 3 October 2014; Published 29 October 2014
Academic Editor: Virinder S. Parmar
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Mondal, Rina; Samanta, Swati; Sarkar, Saheli; Mallik, Asok K.|
|Publication:||International Scholarly Research Notices|
|Date:||Jan 1, 2014|
|Previous Article:||Ion slip effect on viscoelastic fluid flow past an impulsively started infinite vertical plate embedded in a porous medium with chemical reaction.|
|Next Article:||Development and validation of an affinity chromatography-protein G method for IgG quantification.|